title: [Drugs news].
authors.affiliation: Département de pharmacologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
authors.forename: T
authors.initials: T
authors.lastname: Bejan-Angoulvant
authors.affiliation: Département de pharmacologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
authors.forename: F
authors.initials: F
authors.lastname: Beau-Salinas
authors.affiliation: Département de pharmacologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
authors.forename: C
authors.initials: C
authors.lastname: Lengellé
authors.affiliation: Département de pharmacologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
authors.forename: H
authors.initials: H
authors.lastname: Cissoko
authors.affiliation: Département de pharmacologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France. Electronic address: jonville-bera@chu-tours.fr.
authors.forename: A-P
authors.initials: AP
authors.lastname: Jonville-Béra
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects*; D001724:Birth Weight / Q000187:drug effects*; D004198:Disease Susceptibility; D005260:Female; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D007107:Immune System / Q000187:drug effects* / Q000196:embryology; D007231:Infant, Newborn; D007239:Infections / Q000209:etiology; D000069285:Infliximab; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D000077236:Topiramate; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000927:Anticonvulsants; D014409:Tumor Necrosis Factor-alpha; D000077236:Topiramate; D005632:Fructose; D000069285:Infliximab; D000068879:Adalimumab